FDA Inspection 1228256 — Houston Nutraceuticals, Inc d.b.a Houston Enzymes
The FDA completed an inspection of Houston Nutraceuticals, Inc d.b.a Houston Enzymes on February 1, 2024 in Siloam Springs, AR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 1, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Siloam Springs, AR (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15673 | 21 CFR 111.315(a) | Criteria for establishing specifications |
| 15921 | 21 CFR 111.95(b)(2) | Documentation - supplier qualification |
| 15983 | 21 CFR 111.123(a)(7) | Quality control operations - finished batch, specifications |